Form EFFECT Silexion Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 9:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boster Bio Expands Access to Affordable ELISA Kits With 40% Savings on 500 Popular Assays
- New Screenings of The King of Trash Show What It Took David Duong To Build Green Waste Recycling Giant California Waste Solutions
- Meritage Initiates Voluntary Chapter 11 Process to Strengthen Its Balance Sheet and Position the Company for Long-Term Success
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share